STAAR SURGICAL COSTAAEarnings & Financial Report
Nasdaq
STAA Q3 2025 Key Financial Metrics
Revenue
$94.7M
Gross Profit
$77.9M
Operating Profit
$18.5M
Net Profit
$8.9M
Gross Margin
82.2%
Operating Margin
19.5%
Net Margin
9.4%
YoY Growth
6.9%
EPS
$0.18
Financial Flow
STAAR SURGICAL CO Q3 2025 Financial Summary
STAAR SURGICAL CO reported revenue of $94.7M for Q3 2025, with a net profit of $8.9M (9.4% margin). Cost of goods sold was $16.9M, operating expenses totaled $59.4M.
Key Financial Metrics
| Total Revenue | $94.7M |
|---|---|
| Net Profit | $8.9M |
| Gross Margin | 82.2% |
| Operating Margin | 19.5% |
| Report Period | Q3 2025 |
STAAR SURGICAL CO Annual Revenue by Year
STAAR SURGICAL CO annual revenue history includes year-by-year totals (for example, 2024 revenue was $313.9M).
| Year | Annual Revenue |
|---|---|
| 2024 | $313.9M |
| 2023 | $322.4M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76.3M | $77.4M | $99.0M | $88.6M | $49.0M | $42.6M | $44.3M | $94.7M |
| YoY Growth | N/A | 5.2% | 7.3% | 10.3% | -35.8% | -44.9% | -55.2% | 6.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $488.7M | $492.5M | $512.7M | $537.6M | $509.5M | $457.4M | $437.8M | $456.4M |
| Liabilities | $102.7M | $99.7M | $103.6M | $109.5M | $112.2M | $107.4M | $101.2M | $102.6M |
| Equity | $386.0M | $392.8M | $409.1M | $428.1M | $397.3M | $350.0M | $336.6M | $353.8M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $32.0M | $21.7M | $-10.4M | $3.8M | $642000 | $-5.7M | $-27.2M | $2.7M |